SI9300128A - Fatty acids microspheres containing enterococcus for use to enhance growth and improve environment quality - Google Patents
Fatty acids microspheres containing enterococcus for use to enhance growth and improve environment quality Download PDFInfo
- Publication number
- SI9300128A SI9300128A SI19939300128A SI9300128A SI9300128A SI 9300128 A SI9300128 A SI 9300128A SI 19939300128 A SI19939300128 A SI 19939300128A SI 9300128 A SI9300128 A SI 9300128A SI 9300128 A SI9300128 A SI 9300128A
- Authority
- SI
- Slovenia
- Prior art keywords
- microbes
- diet
- direct
- fatty acid
- approx
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 36
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 36
- 239000000194 fatty acid Substances 0.000 title claims abstract description 36
- 150000004665 fatty acids Chemical class 0.000 title claims abstract description 36
- 239000004005 microsphere Substances 0.000 title claims abstract description 36
- 230000012010 growth Effects 0.000 title claims abstract description 24
- 241000194033 Enterococcus Species 0.000 title claims description 7
- 241001465754 Metazoa Species 0.000 claims abstract description 17
- 241000194031 Enterococcus faecium Species 0.000 claims abstract description 11
- 235000005911 diet Nutrition 0.000 claims description 58
- 235000013305 food Nutrition 0.000 claims description 56
- 230000037213 diet Effects 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 40
- 235000016709 nutrition Nutrition 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 21
- 235000021588 free fatty acids Nutrition 0.000 claims description 13
- 241000287828 Gallus gallus Species 0.000 claims description 11
- 235000021355 Stearic acid Nutrition 0.000 claims description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 10
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 9
- 239000008117 stearic acid Substances 0.000 claims description 9
- 235000013372 meat Nutrition 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 4
- 230000001737 promoting effect Effects 0.000 claims description 3
- XIWFQDBQMCDYJT-UHFFFAOYSA-M benzyl-dimethyl-tridecylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 XIWFQDBQMCDYJT-UHFFFAOYSA-M 0.000 claims description 2
- 235000019730 animal feed additive Nutrition 0.000 claims 1
- 235000008429 bread Nutrition 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 230000001502 supplementing effect Effects 0.000 claims 1
- 230000006872 improvement Effects 0.000 abstract description 10
- 239000003674 animal food additive Substances 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 description 30
- 239000000047 product Substances 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 26
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 18
- 230000008569 process Effects 0.000 description 17
- 244000144977 poultry Species 0.000 description 16
- 235000013594 poultry meat Nutrition 0.000 description 16
- 239000003242 anti bacterial agent Substances 0.000 description 15
- 229940088710 antibiotic agent Drugs 0.000 description 15
- 210000000481 breast Anatomy 0.000 description 15
- 241000271566 Aves Species 0.000 description 12
- 230000000378 dietary effect Effects 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 241000282887 Suidae Species 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- 230000037396 body weight Effects 0.000 description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 7
- 235000013330 chicken meat Nutrition 0.000 description 7
- 238000005538 encapsulation Methods 0.000 description 7
- 238000005453 pelletization Methods 0.000 description 7
- 210000000813 small intestine Anatomy 0.000 description 7
- 244000144992 flock Species 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 6
- 235000021395 porridge Nutrition 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 235000019764 Soybean Meal Nutrition 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 230000003442 weekly effect Effects 0.000 description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 239000007952 growth promoter Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000004455 soybean meal Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 235000019738 Limestone Nutrition 0.000 description 3
- 241000286209 Phasianidae Species 0.000 description 3
- 239000004188 Virginiamycin Substances 0.000 description 3
- 108010080702 Virginiamycin Proteins 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000006028 limestone Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000000153 supplemental effect Effects 0.000 description 3
- 235000019373 virginiamycin Nutrition 0.000 description 3
- 229960003842 virginiamycin Drugs 0.000 description 3
- ZNAIHAPCDVUWRX-DUCUPYJCSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;4-amino-n-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-t Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1.C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O ZNAIHAPCDVUWRX-DUCUPYJCSA-N 0.000 description 2
- 108010001478 Bacitracin Proteins 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- 229930182504 Lasalocid Natural products 0.000 description 2
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004182 Tylosin Substances 0.000 description 2
- 229930194936 Tylosin Natural products 0.000 description 2
- 235000019742 Vitamins premix Nutrition 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960003071 bacitracin Drugs 0.000 description 2
- 229930184125 bacitracin Natural products 0.000 description 2
- 239000011449 brick Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 2
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 2
- 230000005757 colony formation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- BBMULGJBVDDDNI-OWKLGTHSSA-N lasalocid Chemical compound C([C@@H]1[C@@]2(CC)O[C@@H]([C@H](C2)C)[C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC=2C(=C(O)C(C)=CC=2)C(O)=O)C[C@](O)(CC)[C@H](C)O1 BBMULGJBVDDDNI-OWKLGTHSSA-N 0.000 description 2
- 229960000320 lasalocid Drugs 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 2
- 229960005287 lincomycin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 229960002135 sulfadimidine Drugs 0.000 description 2
- ASWVTGNCAZCNNR-UHFFFAOYSA-N sulfamethazine Chemical compound CC1=CC(C)=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 ASWVTGNCAZCNNR-UHFFFAOYSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229960004059 tylosin Drugs 0.000 description 2
- 235000019375 tylosin Nutrition 0.000 description 2
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- POMORUSPLDFVEK-PHXAWWDYSA-N (4r)-5-[[(2s,3s)-1-[[(2s)-6-amino-1-[[(2r)-5-amino-1-[[(2s,3s)-1-[[(2r)-1-[[(2s)-1-[[(2r)-1-[[(1s)-3-amino-1-carboxy-3-oxopropyl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methy Chemical compound OC1=CC=CC=C1C(=O)OCOC(=O)C1=CC=CC=C1O.C1SC(C(N)C(C)CC)=NC1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 POMORUSPLDFVEK-PHXAWWDYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000019783 Bacitracin Methylene Disalicylate Nutrition 0.000 description 1
- OVGGLBAWFMIPPY-WUXMJOGZSA-N Carbadox Chemical compound C1=CC=CC2=[N+]([O-])C(/C=N/NC(=O)OC)=C[N+]([O-])=C21 OVGGLBAWFMIPPY-WUXMJOGZSA-N 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000019735 Meat-and-bone meal Nutrition 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 239000004189 Salinomycin Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 239000006030 antibiotic growth promoter Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 229940032022 bacitracin methylene disalicylate Drugs 0.000 description 1
- 108010054309 bacitracin methylenedisalicylic acid Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960000427 carbadox Drugs 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940007210 ivomec Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- BPMVRAQIQQEBLN-OBPBNMOMSA-N methyl n-[(e)-(1-hydroxy-4-oxidoquinoxalin-4-ium-2-ylidene)methyl]iminocarbamate Chemical compound C1=CC=C2N(O)C(=C/N=NC(=O)OC)/C=[N+]([O-])C2=C1 BPMVRAQIQQEBLN-OBPBNMOMSA-N 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960001548 salinomycin Drugs 0.000 description 1
- 235000019378 salinomycin Nutrition 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Birds (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85269292A | 1992-03-17 | 1992-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI9300128A true SI9300128A (en) | 1993-09-30 |
Family
ID=25313993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI19939300128A SI9300128A (en) | 1992-03-17 | 1993-03-17 | Fatty acids microspheres containing enterococcus for use to enhance growth and improve environment quality |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0631616A4 (fr) |
| JP (1) | JP2849877B2 (fr) |
| BG (1) | BG99113A (fr) |
| BR (1) | BR9306121A (fr) |
| CA (1) | CA2131790A1 (fr) |
| CZ (1) | CZ225394A3 (fr) |
| HU (1) | HUT67965A (fr) |
| MX (1) | MX9301017A (fr) |
| RO (1) | RO112896B1 (fr) |
| RU (1) | RU2109052C1 (fr) |
| SI (1) | SI9300128A (fr) |
| SK (1) | SK111694A3 (fr) |
| WO (1) | WO1993019162A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5292657A (en) * | 1990-12-31 | 1994-03-08 | Pioneer Hi-Bred International, Inc. | Process for preparing rotary disc fatty acid microspheres of microorganisms |
| WO1997045530A1 (fr) * | 1996-05-27 | 1997-12-04 | UZILOVA, Irina Semenovna, Heiress of UZILOV | Utilisation de souches de streptococcus faecium et composition a base de ces souches |
| WO2005018654A1 (fr) * | 2003-08-26 | 2005-03-03 | Obschestvo S Ogranichennoi Otvetstvennostyu Alef-Farma | Utilisation de souches de enterococcus faecium pour traiter l'insuffisance hepatique, pour regenerer et pour intensifier le metabolisme hepatique |
| DK1715755T3 (en) * | 2004-02-03 | 2015-03-09 | Prevtec Microbia Inc | Use of live bacteria to promote growth in animals |
| ITMI20120131A1 (it) | 2012-02-01 | 2013-08-02 | Probiotical Spa | Batteri probiotici microincapsulati multistrato, loro produzione ed uso |
| CN112843043B (zh) * | 2021-02-20 | 2023-03-14 | 华中农业大学 | 盐霉素在制备抗冠状病毒药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2016043A (en) * | 1978-03-08 | 1979-09-19 | Danochemo As | Bacteria-containing product for use in animal feeds, and its production |
| KR920006865B1 (ko) * | 1984-05-18 | 1992-08-21 | 워싱톤 유니버시티 테크놀러지 어소우시에이츠 인코오퍼레이티드 | 입자나 액적을 피복하는 방법과 장치 |
| US5292657A (en) * | 1990-12-31 | 1994-03-08 | Pioneer Hi-Bred International, Inc. | Process for preparing rotary disc fatty acid microspheres of microorganisms |
| ES2100951T3 (es) * | 1990-12-31 | 1997-07-01 | Pioneer Hi Bred Int | Bacterias microencapsuladas en acido graso con disco giratorio, secadas. |
| CZ280601B6 (cs) * | 1991-09-20 | 1996-03-13 | Pioneer Hi-Bred International, Inc. | Způsob podpory růstu drůbeže a enterokoky mikrozapouzdřené mastnými kyselinami pro použití u drůbeže |
-
1993
- 1993-02-03 RO RO94-01518A patent/RO112896B1/ro unknown
- 1993-02-03 SK SK1116-94A patent/SK111694A3/sk unknown
- 1993-02-03 EP EP93904784A patent/EP0631616A4/fr not_active Withdrawn
- 1993-02-03 CZ CZ942253A patent/CZ225394A3/cs unknown
- 1993-02-03 JP JP5516534A patent/JP2849877B2/ja not_active Expired - Lifetime
- 1993-02-03 BR BR9306121A patent/BR9306121A/pt not_active Application Discontinuation
- 1993-02-03 CA CA002131790A patent/CA2131790A1/fr not_active Abandoned
- 1993-02-03 RU RU94043791A patent/RU2109052C1/ru active
- 1993-02-03 HU HU9402673A patent/HUT67965A/hu unknown
- 1993-02-03 WO PCT/US1993/000867 patent/WO1993019162A1/fr not_active Ceased
- 1993-02-24 MX MX9301017A patent/MX9301017A/es unknown
- 1993-03-17 SI SI19939300128A patent/SI9300128A/sl unknown
-
1994
- 1994-10-17 BG BG99113A patent/BG99113A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT67965A (en) | 1995-05-29 |
| SK111694A3 (en) | 1995-07-11 |
| RU94043791A (ru) | 1997-03-10 |
| MX9301017A (es) | 1993-09-30 |
| RO112896B1 (ro) | 1998-01-30 |
| JP2849877B2 (ja) | 1999-01-27 |
| EP0631616A1 (fr) | 1995-01-04 |
| WO1993019162A1 (fr) | 1993-09-30 |
| BR9306121A (pt) | 1998-01-13 |
| CZ225394A3 (en) | 1995-01-18 |
| RU2109052C1 (ru) | 1998-04-20 |
| JPH07505056A (ja) | 1995-06-08 |
| EP0631616A4 (fr) | 1995-04-19 |
| CA2131790A1 (fr) | 1993-09-30 |
| HU9402673D0 (en) | 1994-11-28 |
| BG99113A (en) | 1995-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kutlu | Influences of wet feeding and supplementation with ascorbic acid on performance and carcass composition of broiler chicks exposed to a high ambient temperature | |
| Davis et al. | The effects of feeding the direct-fed microbial, primalac, on growth parameters and egg production in single comb white leghorn hens | |
| PL193320B1 (pl) | Zastosowanie mieszaniny zawierającej gwajakol, tymol, engenol, kapsaicynę, taninę i krezol | |
| Morris et al. | Effect of processing methods on utilization of feather meal by broiler chicks | |
| RU2093571C1 (ru) | Способ стимулирования роста домашней птицы и препарат на основе пробиотика | |
| SI9300128A (en) | Fatty acids microspheres containing enterococcus for use to enhance growth and improve environment quality | |
| Atkinson et al. | Vitamin B12, an APF concentrate, aureomycin, streptomycin, Liver “L” and fish meal and fish solubles in the nutrition of the poult | |
| Hale et al. | The effect of low-level diethylstilbestrol implantation, oxytetracycline and hydroxyzine on fattening lambs | |
| JPS61119145A (ja) | 抗胞子虫組成物 | |
| Spais et al. | Effect of Genex, a feed additive containing organic acids and herb extracts, on the performance of broiler chickens | |
| Gomathi et al. | Effect of cinnamon oil and sodium butyrate on growth performance of broilers | |
| Pasaribu et al. | The influence of the mixture of some plant powder with Anacardium occidentale shell liquid smoke on total bacteria and Escherichia coli in the ileum of broiler | |
| Jadhao et al. | Effect of supplementation of acidifiers with probiotic on performance of broiler chicken | |
| Youssef et al. | Mandarah Male Chicks Productive Performance and Organs Weight as Affected by Using Various Routes of Synbiotics Treatments. | |
| Ogbonna et al. | EFFECT OF WED FEED ON COCKEREL CHICKEN PERFORMANCE | |
| Omoikhoje et al. | Carcass traits and internal organs of broiler chickens as influenced by coffee weed (Senna occidentalis) leaf ethanolic extract | |
| Maghrabi et al. | Nutritional requirements in hyperthyroidism of growing chicks | |
| Dorra et al. | EFFECT OF FEEDING DIFFERENT LEVELS OF YELLOW CORN WITH OR WITHOUT MULTI-ENZYMES OR PREBIOTIC SUPPLEMENTATION ON GROWTH PERFORMANCE AND ECONOMICAL EFFICIENCY IN GROWING RABBIT RATIONS | |
| MAIKASUWA | ECONOMIC ANALYSIS OF PROBIOTICS AND HIGH FIBRE DIET IN BROILER STARTER CHICKS’PRODUCTION | |
| Bansal | Performance of commercial broiler chicks as affected by the supplementation of both probiotics and enzymes | |
| Solanki et al. | Effect of dietary supplementation of neem leaf meal and citric acid on growth performance and cost economics of broiler chickens | |
| Abou Zied et al. | Effect of virginiamycin or lacto-sacc on the growth performance of nile tilapia fish during the nursing period | |
| WO2023170591A2 (fr) | Nouvelle supplémentation en ménaquinone-n (vitamine k2-7) pour le bétail et la volaille | |
| WO2024077194A9 (fr) | Microbes à alimentation directe utilisant b. coagulans | |
| El-Refaai et al. | EFFECT OF THE PROBIOTIC ON BROILER GROWTH PERFORMANCE, MORTALITY RATE, INTESTINAL MICROBIAL POPULATIONS AND IMMUNE ORGANS |